Clinical Trial Update: Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial update on combining interferon-alpha with metronomic cyclophosphamide in neuroendocrine tumors has completed recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Interferon-alpha (interferon alpha)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Neuroendocrine Tumors | Phase 2 | Status: COMPLETED